M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
Science Advances · 2023
DOI: 10.1126/sciadv.adf8522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Isabel Weinhäuser und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Net…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
It is increasingly becoming clear that cancers are a symbiosis of diverse cell types and tumor clones. Combined single-cell RNA sequencing, flow cytometry, and immunohistochemistry studies of the innate immune compartment in the bone marrow of patients with acute myeloid leukemia (AML) reveal a shift toward a tumor-supportive M2-polarized macrophage landscape with an altered transcriptional program, with enhanced fatty acid oxidation and NAD + generation. Functionally, these AML-associated macrophages display decreased phagocytic activity and intra–bone marrow coinjection of M2 macrophages together with leukemic blasts strongly enhances in vivo transformation potential. A 2-day in vitro exposure to M2 macrophages results in the accumulation of CALR low leukemic blast cells, which are now protected against phagocytosis. Moreover, M2-exposed “trained” leukemic blasts display increased mitochondrial metabolism, in part mediated via mitochondrial transfer. Our study provides insight into the mechanisms by which the immune landscape contributes to aggressive leukemia development and provides alternatives for targeting strategies aimed at the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
- Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.
- Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil.
- Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK.
- Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
- Medical Oncology Service, Sao Paulo State Cancer Institute, University of Sao Paulo, Brazil.
ORCID-Profile: Isabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, Jacobien R Hilberink, Douglas R A Silveira, Lynn Quek, Cesar Ortiz, Cleide L Araujo, Antonio Lucena-Araujo, Jose Mauricio Mota, Shanna M Hogeling, Dominique Sternadt, Arjan Diepstra, Emanuele Ammatuna, Eduardo M Rego, Jan Jacob Schuringa
Zitieren
APA
Weinhäuser, I., Pereira-Martins, D. A., Almeida, L. Y., Hilberink, J. R., Silveira, D. R. A., Quek, L., Ortiz, C., Araujo, C. L., Bianco, T. M., Lucena-Araujo, A., Mota, J. M., Hogeling, S. M., Sternadt, D., Visser, N., Diepstra, A., Ammatuna, E., Huls, G., Rego, E. M., & Schuringa, J. J. (2023). M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. Science Advances. https://doi.org/10.1126/sciadv.adf8522
Vancouver
Weinhäuser I, Pereira-Martins DA, Almeida LY, Hilberink JR, Silveira DRA, Quek L, et al. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. Science Advances. 2023. doi:10.1126/sciadv.adf8522
BibTeX
@article{Weinhuser2023,
author = {Weinhäuser, Isabel and Pereira-Martins, Diego A and Almeida, Luciana Y and Hilberink, Jacobien R and Silveira, Douglas R A and Quek, Lynn and Ortiz, Cesar and Araujo, Cleide L and Bianco, Thiago M and Lucena-Araujo, Antonio and Mota, Jose Mauricio and Hogeling, Shanna M and Sternadt, Dominique and Visser, Nienke and Diepstra, Arjan and Ammatuna, Emanuele and Huls, Gerwin and Rego, Eduardo M and Schuringa, Jan Jacob},
title = {M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adf8522}
}
EUVIMED